Characteristics | No. (%) |
---|---|
Age, median (range) | 50 (18–76) |
< 50 | 120 (49.6) |
≥ 50 | 122 (50.4) |
Sex | |
Male | 173 (71.5) |
Female | 69 (28.5) |
AJCC 8th T stage | |
T1 | 104 (43.0) |
T2 | 138 (57.0) |
AJCC 8th N stage | |
N0 | 30 (12.4) |
N1 | 212 (87.6) |
AJCC 8th subgroup | |
T1N1M0 | 104 (43.0) |
T2N0M0 | 31 (12.8) |
T2N1M0 | 107 (44.2) |
GTVnx volume (cm3), median (range) | 19.1 (2.1–74.0) |
< 13.7 | 70 (28.9) |
≥ 13.7 | 172 (71.1) |
GTVnd volume (cm3), median (range) | 8.7 (0–71.0) |
< 29.1 | 212 (87.6) |
≥ 29.1 | 30 (12.4) |
Lateral of RPLNs | |
None | 90 (37.2) |
Unilateral | 113 (46.7) |
Bilateral | 39 (16.1) |
LN located in level III | |
Yes | 195 (80.6) |
No | 47 (19.4) |
LN size (cm) | 1.7 (0–6.0) |
MAD < 2.2 | 152 (62.8) |
MAD ≥ 2.2 | 90 (37.2) |
Number of positive LN | 2 (0– 9) |
0 | 30 (12.4) |
1 | 69 (28.5) |
2 | 60 (24.8) |
3 | 51 (21.1) |
4 | 19 (7.9) |
≥ 5 | 13 (5.4) |
†ENE grade | |
Grade 0 | 153 (63.2) |
Grade 1,2 | 52 (21.5) |
Grade 3 | 37 (15.3) |
CNN | |
No | 179 (74.0) |
Yes | 63 (26.0) |
Treatment | |
IMRT | 158 (65.3) |
CCRT | 84 (34.7) |